1. Catalog
  2. SUD 101: Managing Complications and Infections in ...
SUD 101: Managing Complications and Infections in Patients with Opioid Use Disorder
Create Account
Availability
On-Demand
Release on Jun 10, 2026 12:00 AM Central Daylight Time
Access expires on Jun 10, 2029
Cost
$0.00
Credit Offered
1 CME Credit
1 PA-CME Credit
1 Other Professionals Credit
1 Nursing Credit
1 Pharmacy Credit
1 IPCE Credit
  • Course and Curriculum Overview
  • Course Completion & Accreditation
  • Recommended


Course Title: Managing Complications and Infections in Patients with Opioid Use Disorder

Presenter(s): Jeanette M Tetrault, MD

Course Description: Medical complications are common among patients who inject drugs. Signs and symptoms of acute or chronic infectious diseases often prompt patients to seek medical care. The time of presentation for complications related to injection drug use presents an opportunity to screen and employ early intervention strategies and engage individuals in addiction treatment. This course reviews features of skin and soft tissue infections among people who inject drugs, reviews risk factors for Hepatitis C (HCV) and HIV, describes prevention interventions for HCV and HIV, and discusses treatment approaches for HCV and HIV in patients with opioid use disorder. 

Educational Objectives:
At the conclusion of this activity, participants should be able to:

  • Recognize exposure and risk factors for acute and chronic injection-related infections.

  • Define epidemiologic trends of injection drug use related infective endocarditis (IDU-IE) in the US.

  • Propose treatment and prevention opportunities for healthcare teams to address Hepatitis C (HCV) and HIV in patients with substance use disorder.

Curriculum Overview: Healthcare professionals are often on the front lines of treating substance use disorders (SUDs), yet many have limited formal training in this area. The SUD 101 Core Curriculum is designed to build a strong foundation in current research, evidence-based practices, and available resources.

The curriculum includes:

  • Foundational Courses: Eight interactive, case-based courses that simulate real-world clinical scenarios and provide foundational SUD training
  • Supplemental Courses: These courses offer a deeper exploration of specialized topics and expand on core concepts

Together, these courses enhance healthcare professionals’ competence and confidence in caring for patients with SUDs across the continuum of care, with a particular focus on opioid use disorders (OUD).

 

This is a supplemental course within the SUD 101 Core Curriculum. Visit the SUD 101 Core Curriculum page to explore additional educational trainings as new courses become available.

Course Components:

  • Interactive learning: interactive presentation with knowledge checks and reflection questions.
  • Resources: Downloadable slide deck, resource links, references, and mentorship opportunities.
  • Team-based takeaway guide: This tool provides important course takeaways from and for specific members of the team. It was designed to help the team learn from and about one another.
  • Accredited CE credits: A certificate following completion of the course


Requirements for Successful Activity Completion:
To complete this activity and obtain your Certificate, please follow the steps below:

  1. Course Content:
    Complete the interactive presentation (30-60 minutes).

  2. Evaluation:
    Click Evaluation to complete the final PCSS-MOUD course evaluation.

  3. Claim your Certificate:
    Select and claim your preferred certificate type on the next page. Once claimed, a download button will appear in your Certificate Tab. If you do not see the download button or cannot access your certificate, return to the course evaluation and claim your preferred credit/certificate.

  4. Post Survey:
    90 Days following your completion of this activity, you will receive a survey (2 questions) to ask about changes in your practice


Accreditation statement


In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 


Credit Designation Statements:

Physicians

American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses and Nurse Practitioners

American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 CNE credits.

Pharmacists

This activity has been approved for 1 hour of pharmacy continuing education credit. The approval number issued is Universal Activity Number: UAN JA4008192-0000-26-053-H08-P.

PAs

PA AAPA Category 1 CME

American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until June 10, 2029. PAs should only claim credit commensurate with the extent of their participation.


Other Health Professionals and Other Learners

Participants will receive a certificate stating this program is designated for 1 AMA PRA Category 1 Credits™.  This credit is accepted by the AANP and the AAPA. 

All Learners

IPCE_Credit

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.


Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org
Powered By